Status:
COMPLETED
Shoe Orthotics for Improvement of Biomechanics and Symptoms of Knee Osteoarthritis
Lead Sponsor:
University of British Columbia
Collaborating Sponsors:
Pedorthic Research Foundation of Canada
Kintec Footlabs
Conditions:
Knee Osteoarthritis
Eligibility:
All Genders
50-80 years
Phase:
NA
Brief Summary
Knee osteoarthritis (OA) is a widespread problem in Canada, leading to decreased quality of life and increased economic burden. Current research has focused on expensive, invasive treatments, whereas ...
Eligibility Criteria
Inclusion
- i) age 50 - 80 years (to meet the American College of Rheumatology clinical definition of OA)
- ii) medial tibiofemoral OA, defined as medial knee pain on most days of the past month and evidence on radiographs of a definite osteophyte in the medial tibiofemoral compartment
- iii) pronated feet, defined as a foot posture index that is 0.5 standard deviations above the reported population mean.
Exclusion
- i) low pain score on a numerical rating scale of pain (average knee pain on walking ≤3 out of 10 over previous week) to allow detection of treatment response
- ii) knee surgery or intra-articular corticosteroid injection within the previous six months
- iii) current or recent (within 4 weeks) oral corticosteroid use
- iv) any muscular, joint or neurological condition affecting lower limb within the past 6 months
- v) ankle/foot pathology or pain that precludes the use of orthotics
- vi) current use of foot orthotics
- vii) use of footwear unable to accommodate an orthotic
- viii) unable to walk without a gait aid
- ix) inability to speak English or have a family member present to translate (required for the validity of the questionnaires)
Key Trial Info
Start Date :
August 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2016
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT02234895
Start Date
August 1 2014
End Date
March 1 2016
Last Update
June 8 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of British Columbia; University Hospital
Vancouver, British Columbia, Canada